Ubiquitin proteasome system in immune regulation and therapeutics.
Ubiquitin proteasome system in immune regulation and therapeutics.
复制标题
免疫调节和治疗中的泛素蛋白酶体系统。
DOI:
10.1016/j.coph.2022.102310
复制
发表时间:
2022-12
影响因子:
4
通讯作者:
中科院分区:
文献类型:
--
作者:
The ubiquitin proteasome system (UPS) is a proteolytic machinery for the degradation of protein substrates that are post-translationally conjugated with ubiquitin polymers through the enzymatic action of ubiquitin ligases, in a process termed ubiquitylation. Ubiquitylation of substrates precedes their proteolysis via proteasomes, a hierarchical feature of UPS. E3-ubiquitin ligases recruit protein substrates providing specificity for ubiquitylation. Innate and adaptive immune system networks are regulated by ubiquitylation and substrate degradation via E3-ligases/UPS. Deregulation of E3-ligases/UPS components in immune cells is involved in the development of lymphomas, neurodevelopmental abnormalities, and cancers. Targeting E3-ligases for therapeutic intervention provides opportunities to mitigate the unintended broad effects of 26S proteasome inhibition. Recently, bifunctional moieties such as PROTACs and molecular glues have been developed to re-purpose E3-ligases for targeted degradation of unwanted aberrant proteins, with a potential for clinical use. Here, we summarize the involvement of E3-ligases/UPS components in immune-related diseases with perspectives.
登录
查看更多内容
影响因子:
5.6
作者:
Gavali S;Liu J;Li X;Paolino M
通讯作者:
Paolino M
影响因子:
9.2
作者:
Shaw, Paul J.;Duntley, Stephen P.
通讯作者:
Duntley, Stephen P.
影响因子:
7.7
作者:
Friedman, Constantin S.;O'Donnell, Marie Anne;Ting, Adrian T.
通讯作者:
Ting, Adrian T.
影响因子:
3.7
作者:
George AJ;Hoffiz YC;Charles AJ;Zhu Y;Mabb AM
通讯作者:
Mabb AM
影响因子:
4.9
作者:
Bonnevier, JL;Zhang, R;Mueller, DL
通讯作者:
Mueller, DL